Clinical trial
UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma
NCT00045500 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00045500 |
|---|---|
| Title | UCN-01 and Prednisone in Treating Patients With Solid Tumors or Lymphoma |
| Official title | A Phase I Trial Of UCN-01 And Prednisone In Patients With Refractory Solid Tumors And Lymphomas |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Drug |
| Interventions | 7-hydroxystaurosporine, prednisone |
| Start date | Jun 1, 2002 |
| Primary completion | Jan 1, 2010 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 30, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: